Dimensional Fund Advisors
LPCN icon

Dimensional Fund Advisors’s Lipocine LPCN Stock Holding History

Dimensional Fund Advisors’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.1K Buy
36,775
+17,653
+92% +$42.5K ﹤0.01% 3144
2026
Q1 		$153K Buy
19,122
+6,982
+58% +$60.8K ﹤0.01% 3093
2025
Q4 		$97.5K Hold
12,140
– – ﹤0.01% 3150
2025
Q3 		$34.7K Sell
12,140
-11,722
-49% -$35.6K ﹤0.01% 3253
2025
Q2 		$75.4K Sell
23,862
-1,073
-4% -$3.48K ﹤0.01% 3209
2025
Q1 		$79.3K Buy
24,935
+4,419
+22% +$17.1K ﹤0.01% 3227
2024
Q4 		$100K Buy
20,516
+2,500
+14% +$12.7K ﹤0.01% 3242
2024
Q3 		$80.9K Buy
18,016
+6,146
+52% +$30.9K ﹤0.01% 3255
2024
Q2 		$97.8K Buy
+11,870
New +$74.2K ﹤0.01% 3252
2019
Q4 		– Sell
-8,451
Closed -$404K – 3397
2019
Q3 		$404K Hold
8,451
– – ﹤0.01% 3179
2019
Q2 		$280K Hold
8,451
– – ﹤0.01% 3276
2019
Q1 		$332K Hold
8,451
– – ﹤0.01% 3232
2018
Q4 		$187K Sell
8,451
-266
-3% -$6.17K ﹤0.01% 3296
2018
Q3 		$205K Hold
8,717
– – ﹤0.01% 3306
2018
Q2 		$193K Sell
8,717
-259
-3% -$6.17K ﹤0.01% 3256
2018
Q1 		$233K Hold
8,976
– – ﹤0.01% 3207
2017
Q4 		$525K Sell
8,976
-414
-4% -$25.7K ﹤0.01% 3090
2017
Q3 		$634K Sell
9,390
-4,888
-34% -$353K ﹤0.01% 3074
2017
Q2 		$976K Sell
14,278
-886
-6% -$57.8K ﹤0.01% 2982
2017
Q1 		$1M Sell
15,164
-83
-0.5% -$5.38K ﹤0.01% 2977
2016
Q4 		$954K Sell
15,247
-1,777
-10% -$112K ﹤0.01% 2974
2016
Q3 		$1.29M Sell
17,024
-406
-2% -$25.2K ﹤0.01% 2879
2016
Q2 		$901K Buy
17,430
+263
+2% +$40.7K ﹤0.01% 2952
2016
Q1 		$2.96M Buy
17,167
+1,210
+8% +$206K ﹤0.01% 2662
2015
Q4 		$3.51M Buy
15,957
+6,732
+73% +$1.41M ﹤0.01% 2647
2015
Q3 		$1.85M Buy
9,225
+5,333
+137% +$1.23M ﹤0.01% 2840
2015
Q2 		$568K Buy
+3,892
New +$483K ﹤0.01% 3120
2015
Q1 		– Sell
-129
Closed -$12K – 3368
2014
Q4 		$12K Buy
+129
New +$10.9K ﹤0.01% 3447

Other funds holding LPCN

SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors's LPCN Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Lipocine (LPCN) stake by 92% in Q2 2026, buying an estimated $42.5K and bringing the position to 36,775 shares worth $94.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3144.

Dimensional Fund Advisors first reported a position in LPCN in Q4 2014 and has held it in 28 quarters since. The position peaked at $3.51M in Q4 2015. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

  • Dimensional Fund Advisors held 36,775 shares of Lipocine worth $94.1K as of Q2 2026.
  • Dimensional Fund Advisors bought 17,653 Lipocine shares in Q2 2026, an estimated $42.5K.
  • Lipocine made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3144 holding.
  • Dimensional Fund Advisors first reported a position in Lipocine in Q4 2014 and has held it in 28 quarters since.
  • Dimensional Fund Advisors's Lipocine position peaked at $3.51M in Q4 2015.
  • 36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.